To continue getting breaking news and the full stories from The Boston Globe, subscribe today.

The Boston Globe

Business

Boston.com

MASS. MOVERS

Cubist opens its expanded R&D space

  March 17, 2012

Cubist Pharmaceuticals Friday officially opened its expanded research and development facility at its Lexington headquarters. The 104,000-square-foot expansion includes state-of-the-art laboratory space for R&D around antibiotics and other acute care products, a molecular modeling room, and office space, Cubist said. Cubist makes the injectable antibiotic daptomycin, which it markets under the brand name Cubicin. Cubicin treats skin and bloodstream infections. The company had revenue of $754 million last year.

Stay with the story. Get full access to BostonGlobe.com for just 99¢

Unlimited access to BostonGlobe.com for only 99¢ for the first 4 weeks. You can cancel at any time.

  • The FULL story all day: Enjoy all of the high-quality, in-depth journalism in the print edition of the Boston Globe — plus breaking news that's updated 24/7.
  • A truly reader-friendly format: It's online news that looks and reads just like the newspaper — uncluttered, uninterrupted.
  • Breakthrough technology: The responsive design automatically adapts content so it always reads perfectly on the digital device of your choice.
Get started today

Free access for home delivery subscribers.

Just need to link your home delivery account; one easy step.

Link my home delivery account

BostonGlobe.comSubscriber Log In

Contact us for help